Logo of pnasPNASInfo for AuthorsSubscriptionsAboutThis Article
Proc Natl Acad Sci U S A. Feb 6, 1996; 93(3): 1325–1329.

Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys.


The selective activation of the prefrontal cortical dopamine system by mild stress can be mimicked by anxiogenic beta-carbolines such as FG7142. To investigate the functional relevance of elevated levels of dopamine turnover in the prefrontal cortex, the current study examined the effects of FG7142 on the performance of spatial working memory tasks in the rat and monkey. FG7142 selectively increased prefrontal cortical dopamine turnover in rats and significantly impaired performance on spatial working memory tasks in both rats and monkeys. Spatial discrimination, a task with similar motor and motivational demands (rats), or delayed response performance following zero-second delays (monkeys) was unaffected by FG7142. Further, biochemical analysis in rats revealed a significant positive correlation between dopamine turnover in the prefrontal cortex and cognitive impairment on the delayed alternation task. The cognitive deficits in both rats and monkeys were prevented by pretreatment with the benzodiazepine receptor antagonist, RO15-1788, which blocked the increase in dopamine turnover and by the dopamine receptor antagonists, haloperidol, clozapine, and SCH23390. These findings indicate that excessive dopamine activity in the prefrontal cortex is detrimental to cognitive functions mediated by the prefrontal cortex.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Roth RH, Tam SY, Ida Y, Yang JX, Deutch AY. Stress and the mesocorticolimbic dopamine systems. Ann N Y Acad Sci. 1988;537:138–147. [PubMed]
  • Deutch AY. Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease. J Neural Transm Gen Sect. 1993;91(2-3):197–221. [PubMed]
  • Bebbington P, Wilkins S, Jones P, Foerster A, Murray R, Toone B, Lewis S. Life events and psychosis. Initial results from the Camberwell Collaborative Psychosis Study. Br J Psychiatry. 1993 Jan;162:72–79. [PubMed]
  • Berman KF, Weinberger DR. The prefrontal cortex in schizophrenia and other neuropsychiatric diseases: in vivo physiological correlates of cognitive deficits. Prog Brain Res. 1990;85:521–537. [PubMed]
  • Goldstein M, Deutch AY. Dopaminergic mechanisms in the pathogenesis of schizophrenia. FASEB J. 1992 Apr;6(7):2413–2421. [PubMed]
  • Davis KL, Kahn RS, Ko G, Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry. 1991 Nov;148(11):1474–1486. [PubMed]
  • Thierry AM, Tassin JP, Blanc G, Glowinski J. Selective activation of mesocortical DA system by stress. Nature. 1976 Sep 16;263(5574):242–244. [PubMed]
  • Tam SY, Roth RH. Modulation of mesoprefrontal dopamine neurons by central benzodiazepine receptors. I. Pharmacological characterization. J Pharmacol Exp Ther. 1990 Mar;252(3):989–996. [PubMed]
  • Deutch AY, Roth RH. The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog Brain Res. 1990;85:367–403. [PubMed]
  • Bradberry CW, Lory JD, Roth RH. The anxiogenic beta-carboline FG 7142 selectively increases dopamine release in rat prefrontal cortex as measured by microdialysis. J Neurochem. 1991 Mar;56(3):748–752. [PubMed]
  • Arnsten AF, Cai JX, Murphy BL, Goldman-Rakic PS. Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology (Berl) 1994 Oct;116(2):143–151. [PubMed]
  • Kolb B. Functions of the frontal cortex of the rat: a comparative review. Brain Res. 1984 Nov;320(1):65–98. [PubMed]
  • McCarthy G, Blamire AM, Puce A, Nobre AC, Bloch G, Hyder F, Goldman-Rakic P, Shulman RG. Functional magnetic resonance imaging of human prefrontal cortex activation during a spatial working memory task. Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8690–8694. [PMC free article] [PubMed]
  • Jonides J, Smith EE, Koeppe RA, Awh E, Minoshima S, Mintun MA. Spatial working memory in humans as revealed by PET. Nature. 1993 Jun 17;363(6430):623–625. [PubMed]
  • Oscar-Berman M. Clinical and experimental approaches to varieties of memory. Int J Neurosci. 1991 Jun;58(3-4):135–150. [PubMed]
  • Wörtwein G, Mogensen J, Divac I. Retention and relearning of spatial delayed alternation in rats after combined or sequential lesions of the prefrontal and parietal cortex. Acta Neurobiol Exp (Wars) 1993;53(2):357–366. [PubMed]
  • de Brabander JM, de Bruin JP, van Eden CG. Comparison of the effects of neonatal and adult medial prefrontal cortex lesions on food hoarding and spatial delayed alternation. Behav Brain Res. 1991 Jan 31;42(1):67–75. [PubMed]
  • Brozoski TJ, Brown RM, Rosvold HE, Goldman PS. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science. 1979 Aug 31;205(4409):929–932. [PubMed]
  • Bubser M, Schmidt WJ. 6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze. Behav Brain Res. 1990 Mar 5;37(2):157–168. [PubMed]
  • Stam CJ, de Bruin JP, van Haelst AM, van der Gugten J, Kalsbeek A. Influence of the mesocortical dopaminergic system on activity, food hoarding, social-agonistic behavior, and spatial delayed alternation in male rats. Behav Neurosci. 1989 Feb;103(1):24–35. [PubMed]
  • Simon H. Neurones dopaminergiques A10 et système frontal. J Physiol (Paris) 1981 Apr;77(1):81–95. [PubMed]
  • Elsworth JD, Deutch AY, Redmond DE, Jr, Taylor JR, Sladek JR, Jr, Roth RH. Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions. Neuroscience. 1989;33(2):323–331. [PubMed]
  • Tam SY, Roth RH. Selective increase in dopamine metabolism in the prefrontal cortex by the anxiogenic beta-carboline FG 7142. Biochem Pharmacol. 1985 May 1;34(9):1595–1598. [PubMed]
  • Dorow R, Horowski R, Paschelke G, Amin M. Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors. Lancet. 1983 Jul 9;2(8341):98–99. [PubMed]
  • Ninan PT, Insel TM, Cohen RM, Cook JM, Skolnick P, Paul SM. Benzodiazepine receptor-mediated experimental "anxiety" in primates. Science. 1982 Dec 24;218(4579):1332–1334. [PubMed]
  • Pellow S, File SE. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav. 1986 Mar;24(3):525–529. [PubMed]
  • Nakane H, Shimizu N, Hori T. Stress-induced norepinephrine release in the rat prefrontal cortex measured by microdialysis. Am J Physiol. 1994 Dec;267(6 Pt 2):R1559–R1566. [PubMed]
  • Williams GV, Goldman-Rakic PS. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature. 1995 Aug 17;376(6541):572–575. [PubMed]
  • Shue KL, Douglas VI. Attention deficit hyperactivity disorder and the frontal lobe syndrome. Brain Cogn. 1992 Sep;20(1):104–124. [PubMed]
  • Gedye A. Tourette syndrome attributed to frontal lobe dysfunction: numerous etiologies involved. J Clin Psychol. 1991 Mar;47(2):233–252. [PubMed]
  • Gotham AM, Brown RG, Marsden CD. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain. 1988 Apr;111(Pt 2):299–321. [PubMed]
  • Robbins TW. The case of frontostriatal dysfunction in schizophrenia. Schizophr Bull. 1990;16(3):391–402. [PubMed]
  • Weinberger DR, Berman KF, Illowsky BP. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. Arch Gen Psychiatry. 1988 Jul;45(7):609–615. [PubMed]
  • Stam CJ, Visser SL, Op de Coul AA, De Sonneville LM, Schellens RL, Brunia CH, de Smet JS, Gielen G. Disturbed frontal regulation of attention in Parkinson's disease. Brain. 1993 Oct;116(Pt 5):1139–1158. [PubMed]
  • Owen AM, James M, Leigh PN, Summers BA, Marsden CD, Quinn NP, Lange KW, Robbins TW. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain. 1992 Dec;115(Pt 6):1727–1751. [PubMed]
  • Růzicka E, Roth J, Spacková N, Mecír P, Jech R. Apomorphine induced cognitive changes in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):998–1001. [PMC free article] [PubMed]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • Compound
    PubChem Compound links
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...